CU Medical Systems, Inc. (KOSDAQ:115480)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,335.00
-5.00 (-0.21%)
At close: Sep 11, 2026

CU Medical Systems Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
62,39948,22340,62941,80346,95735,402
Revenue Growth
52.97%18.69%-2.81%-10.98%32.64%25.01%
Gross Profit
34,61428,43821,46020,32424,64818,422
Operating Income
15,21111,0737,3545,06011,2822,376
Net Income
9,712819.2-3,204-8,2049,425-13,981
Earnings Per Share
774.3767.68-315.00-860.001043.92-2060.53
EPS Growth
------

Revenue by Geography

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
South Korea
8,2208,71410,7098,8946,979
Asia
10,3419,5838,6937,3796,694
Europe
27,18619,62719,35727,34618,784
Middle East
638.95758.59563.09701.6429.46
Africa
79.5882.19113.09134.79118.78
Americas
900.551,0801,5991,3881,292
Oceania
856.87784.41768.941,1141,105
Total
48,22340,62941,80346,95735,402

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
32,13825,37222,2709,8727,03511,845
Total Debt
48,34133,39537,39023,70019,75114,909
Net Cash (Debt)
-16,202-8,022-15,120-13,828-12,716-3,064
Net Cash Growth
------
Net Cash Per Share
-1288.13-662.74-1476.32-1446.14-1408.40-451.60

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
15,0079,68714,0728,2753,121490.43
Capital Expenditures
-1,227-1,058-20,056-6,382-11,586-5,186
Free Cash Flow
13,7808,629-5,9841,893-8,465-4,696
Free Cash Flow Growth
-2.13%-----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
55.47%58.97%52.82%48.62%52.49%52.04%
Operating Margin
24.38%22.96%18.10%12.11%24.03%6.71%
Pretax Margin
15.59%3.13%-6.09%-17.81%22.25%-42.77%
Profit Margin
15.56%1.70%-7.89%-19.63%20.07%-39.49%
FCF Margin
22.08%17.89%-14.73%4.53%-18.03%-13.26%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
3.0240.64--6.32-
P/FCF Ratio
2.053.86-21.69--
PS Ratio
0.450.691.000.981.271.46